Article
Comparative phenotypes of peripheral blood and spleen cells from cancer patients.
International immunopharmacology - 1 Aug 2020
Cole Kathryn E, Ly Quan P, Hollingsworth Michael A, Cox Jesse L, Stromnes Ingunn M, Padussis James C, Foster Jason M, Vargas Luciano M, Talmadge James E
Abstract excerpt
Patients with resectable tumor, either in the body or the tail of the pancreas, and cancer patients with a primary tumor adjacent to the splenic vasculature frequently undergo a splenectomy as standard of care during resection. The spleen provides an unutilized source of lymphocytes with potential utility for adoptive cellular therapy (ACT). In this report, spleen and peripheral blood (PB) cells from cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.